Login
← Go Back
Vaishali Pharma
VAISHALI · Pharma > Pharmaceuticals & Drugs · Chairman: Atul Vasani · MD: Atul Vasani · Listing date: Aug. 23, 2017 · Employees: 32 · Mumbai · http://www.vaishalipharma.com
Stock Price vs Company Growth
1d
0.3%
1w
0.1%
1m
5.2%
3m
44.0%
6m
42.2%
1y
23.4%
5y
23.0%
all
14.4%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec19Dec20Dec21Dec22Dec23Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 12.3 0.3%
11
18.8
Company Overview
Sales
99.2 Cr
Growth: 25.9%
Profit after Tax
0.42 Cr
Growth: -61.2%
Micro Cap
160 Cr
P/E: 14.4x
Industry P/E: 28.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 99.2
Growth 25.9%
EBITDA -0.7%
P/S 1.6x
Dividend 0.0%
P/E 14.4x
Book Value ₹ 3.85
PEG Ratio 0.6x
ROE 0.9%
P/B 3.2x
Shareholding Pattern
Institutions
Samyag Broking Private Limited
1.31 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Dec21Sep22
Promoters
Atul Arvindbhai Vasani
51.63 %
Jagruti Atul Vasani
4.55 %
Bharti Kiritkumar Tolia
1.57 %
Vaishali A Vasani
1.43 %
Punita Kaushik Gandhi
0.04 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Dec21Sep22
Others
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun21Dec21Sep22
Increase    Decrease    No change
Company Profile Detailed
The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others.
Investors (69)
vimal.tr...
shah.sun...
ashish.s...